Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells

Type 1 diabetes (T1D) is an autoimmune disease characterized by destruction of pancreatic β cells. One of the promising therapeutic approaches in T1D is the transplantation of islets; however, it has serious limitations. To address these limitations, immunotherapeutic strategies have focused on rest...

Descripción completa

Detalles Bibliográficos
Autores principales: Oran, D.C., Lokumcu, T., Inceoglu, Y., Akolpoglu, M.B., Albayrak, O., Bal, T., Kurtoglu, M., Erkan, M., Can, F., Bagci-Onder, T., Kizilel, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061575/
https://www.ncbi.nlm.nih.gov/pubmed/32159143
http://dx.doi.org/10.1016/j.mtbio.2019.100006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061575/
https://www.ncbi.nlm.nih.gov/pubmed/32159143
http://dx.doi.org/10.1016/j.mtbio.2019.100006

Ejemplares similares